This article may rely excessively on sources too closely associated with the subject, potentially preventing the article from being verifiable and neutral. (December 2016) (Learn how and when to remove this template message)
S&P 500 Component
|Founded||New York City (1899)|
Dr. Jacob F. Frantz |
George H. Whiteley
Dean C. Osborne
and John R. Sheppard
|Headquarters||York, Pennsylvania, United States|
Bret W. Wise Non-Executive Chairman|
Donald M. Casey Jr. CEO
|Revenue||$3745.30 mil (2016)|
|$429.90 mil (2016)|
|Total assets||$11.656 mil (2016)|
|Total equity||$8126 mil (2016)|
Number of employees
|15,700 (December 2016)|
Dentsply Sirona is an American dental equipment maker and dental consumables producer that markets its products in over 120 countries. It has factories in 21 countries. The present company is largely the result of a merger in 1993 in which Gendex Corporation acquired Dentsply International Inc. for $590 million.
As an equipment maker, it designs and manufactures laboratory and specialty products relating to dental supplies. With regards to consumable products, it specializes in anesthetics, plaque and gum disease prevention (prophylaxis) and tooth polishers. It also designs and constructs artificial teeth. Because of the income disparity between wealthy and developing nations, the variety of products in demand differs from region to region (and thus subsidiary to subsidiary since many of them are regional).
Dentsply was founded by four New York businessmen in 1899 as Dentists' Supply Company, about the same time it made its first acquisition, a Pennsylvania porcelain teeth manufacturer. One of the four founders, George H. Whiteley became the main operator of the company as a result of his experience as a ceramicist. Whiteley's contributions to the company were invaluable as he was responsible for many innovations such as a patented process involving platinum rings that reduced tooth breakage. Other innovations (credited to doctors like James Williams who were hired by the company for research purposes) included better fitting dentures, tooth size for people of different face shapes and age specific colored teeth.
In the early 1920s, the company selected European distributor E.de Trey & Sons as its primary marketer to Europe, however it quickly became the company's main distributor in the US also. A rivalry between De Trey and the main other denture equipment producer at the time, Ash Company, nearly eliminated cash flows due to extreme price cutting. The problem was resolved when the two decided to merge their distribution businesses into one named the Amalgamated Dental Company Limited. In 1925, 45% of Zahnfabrik (artificial teeth producer) was bought by Dentists' Supply and its distributor Amalgamated Dental bought a 30% interest in the manufacturer.
High American tariffs and increased efforts to gain market share abroad, especially in Europe and Australia, led the company to set up more research and manufacturing centers abroad. Its first foreign subsidiary was established in Australia as a means to acquire Natudryl Manufacturing. In the 1950s and 1960s the company developed many of the ideas used by its equipment today like tooth cleaning machine Dentsply Cavitron and Neolux which improved the finish of plastic teeth. The company renamed itself Dentsply International in 1969 due to its products' brand name being more widely recognized.
Key acquisitions by Dentists' Supply Company: LD Caulk Company in 1963, Ransom and Randolph Company in 1964, F&F Koenigkramer Company (chairs and stools). Largest was Amalgamated Dental Industrial (former distributor that played a major role in helping the company grow early on that also controlled Australia's largest dental supply chain) in 1976.
In 1993, after it acquired Gendex Corp in a reverse takeover, the company went public on the Nasdaq. The new company then purchased medical x-ray tubes supplier Eureka X-Ray Inc. which was key since Gendex was a major manufacturer of x-ray systems (Eureka X-Ray was later sold in 1994). Healthco its main distributor in the US went bankrupt in 1993.
In 2010, the most important markets for sales were Europe & CIS (40%), USA (37%), Latin America (5%), Asia (excl CIS and Japan, 5%), Canada (4%), Japan (4%), Middle East & Africa (3%) and Australia (2%). Dentsply holds a leading market share in the dental restorative sector ($4.0 billion according to the company).
In June 2011, Dentsply acquired Astra Tech, the world's third largest maker of dental implants from the Anglo-Swedish pharmaceutical company AstraZeneca for $1.8 billion. The deal raises revenue by 25% ($535M) and was completed on August 31, 2011. Acquisitions in 2011 caused the value of long term debt to increase by 147% while total assets grew by 146% (current assets however decreased in value). Acquisition/restructuring charges were one of the reasons net income decreased 7.4%.
Markets outside the United States are becoming increasingly important: they accounted for 67% of Dentsply revenue in 2013 steady with 2012 but up from 66% and 63% the previous two years. In 2012, acquisitions contributed all of the growth in sales (16.2%, currency effects were -3.8%). 2012 sales growth by region: Europe 27.5% (vs 17.9% in 2011), USA 13.8% (vs 4.9%), elsewhere 15.9% (vs 9.4%). 88% of net sales were in dental products, 12% from consumable medical device products (casting industry).
On February 29, 2016 Dentsply combined with Long Island-based Sirona Dental Systems in a $14.5 billion merger of equals. While both supply dental products, Sirona's business centers on dental equipment in contrast with Dentsply's consumables.
In 2017, CEO Jeffrey Slovin, executive chairman Bret Wise, and president Christopher Clark all resigned. On January 17, 2018 Dentsply Sirona announced the appointment of Donald Casey Jr., formerly CEO of the Medical Segment of Cardinal Health, as CEO and a member of the board, with Casey to take the role in February and succeed interim CEO Mark Thierer.
Many divisions are regional in terms of their base and the market they serve (most in Asia are named after the country they serve) while others are focused on a specific product (e.g. Maillefer in endodontics). The divisions and subsidiaries sell their products through regionally focused distribution companies as well as dentists and dental schools.
- Dentsply; Africa, Middle East, Asia, South Africa, North America, Canada, Mexico, South America, Argentina, Brazil, Chile, Colombia, Australia
- Asia, China, India, Indonesia, Japan, Korea, Philippines, Taiwan, Thailand, Vietnam, France, Italia, Maillefer, Nordics, Poland, Portugal
- Russia (CIS), Spain, Switzerland/Austria, United Kingdom, Czech Republic, Benelux
Product specific Dentsply divisions and subsidiaries
- Friadent, Pharmaceutical - anesthetics
- Professional - preventive, handpieces & burs
- Prosthetics - lab products
- Raintree Essix - orthodontics, plastics
- Ransom & Randolph - investment casting materials
- Rinn - x-ray accessories/Crescent
- Trubyte - removable full dentures
- Tulsa - endodontics and implants
- Austenal - removable partial dentures
- Caulk - restoratives/impression materials
- Ceramco - crown and bridge
- Friadent Ceramed - implants and grafting
- GAC - orthodontics
- Glenroe - orthodontics
- Maillefer - endodontics
- Astra Tech AB - Dental implants and surgical products
Products comprise 3 general groups; dental consumables, dental laboratory products and dental specialty products. In addition the company receives about 2 to 3% of its revenue from the sale of precious metal content.
Dental consumable products (30%, 28%, 33%, 35% of sales in '13 '12 '11 '10) refers to such products as dental sundries (more than 100 brand names market sundries), dental anesthetics, prophylaxis paste, restorative materials, dental sealants, tooth whiteners, and topical fluoride, basically things that need to be replaced regularly. This segment also includes hand equipment like polishers and light systems.
Dental laboratory products (10%, 11%, 14%, 16% of sales in '13 12 '11 '10) includes dental prosthetics, including artificial teeth, precious metal dental alloys, dental ceramics, and crown and bridge materials and equipment like computer aided machining systems.
Dental specialty products (60%, 61%, 53%, 53% of sales in '13 '12 '11 '10) consists of endodontic instruments and materials, implants and related products, bone grafting materials, 3D digital implantology (the marketing and distribution of which was enhanced in 2009 with the acquisition of a company in that business), and orthodontic appliances and accessories.
These products are marketed under a number of brand names including ankylos, aquasil, aquasil ultra, biopure, caulk, cavitron, ceramco, cercon, citanest, delton, dentsply, detrey, elephant, esthet.x, friadent, frialit, gac orthoworks, golden gate, in-ovation, interactive mystique, maillefer, midwest, nupro, oraqix, pepgen P-15, polocaine, prime & bond, profile, protaper, rinn, r&r, sani-tip, seal&protect, shadepilot, thermafil, trubyte, xeno and xylocaine.'
- little known stocks
- "Gendex and Dentsply to merge in $590 million deal". The New York Times. 1992-12-18.
- Securities and Exchange Commission
- "Dentsply 2010 Investor Presentation page 9 of 27" (PDF). 2011-03-11.
- "See headlines for XRAY View Print Version More from GlobeNewswire Dentsply Sirona Announces the Addition of New Board Members Donald M. Casey Jr. Appointed Chief Executive Officer of Dentsply Sirona Inc. Dentsply Sirona to Present at the 36th Annual J.P. Morgan Healthcare Conference Referenced Stocks XRAY 100% Rate It Donald M. Casey Jr. Appointed Chief Executive Officer of Dentsply Sirona Inc." Globalnewswire. January 17, 2018. http://www.nasdaq.com/press-release/donald-m-casey-jr-appointed-chief-executive-officer-of-dentsply-sirona-inc-20180117-00316
- History of Dentsply International Inc
- Varian Completes Purchase
- Life After Healthco
- "Dentsply International 2011 Annual Report". 2012-02-24.
- "Dentsply 2010 Financial Results" (PDF). 2011.
- "DENTSPLY International Completes Acquisition of Astra Tech". August 31, 2011.[permanent dead link]
- Krauskopf, Lewis (June 22, 2011). "Dentsply buys Astra Tech for $1.8 billion". Reuters.
- "DENTSPLY International Inc. Reports Fourth Quarter and Fiscal 2011 Results". 2012-02-16.
- "Dentsply 2013 Annual Report". 2014.
- "Denstply 2012 Annual Filing". February 20, 2013.
- Lombardo, Cara (January 17, 2018). "Dentsply Sirona Taps Outsider for CEO After Forced Resignations". The Wall Street Journal. New York City, New York. Retrieved January 18, 2018.
- "Dentsply 2009 Annual Report" (PDF). 2010-02-10. Archived from the original (PDF) on 2010-11-21.